Abstract CT127: A phase I study of cMET inhibitor bozitinib in patients with advanced NSCLC harboring <i>cMET</i> alterationsJin‐Ji Yang, Yi‐Long Wu, Huajun Chen et al.|Cancer Research|2020Cited by 18